Formulary Monographs [METAMIZOL, 280892]

METAMIZOL
ANALGESICS AND PYRETICS MISCELLANEOUS
Dengue fever where no alternative is available or suitable.
Administration is associated withincreased risk of agranulocytosis, anaphylactic shock. Severe cutaneous reactions, bronchospasm.
Tabs: 500mg-4g daily in divided doses. Drops: 0.1-0.5 ml daily .
See BDS supply protocols pg. 4.